MUFG Americas’s Jazz Pharmaceuticals JAZZ Stock Holding History

MUFG Americas’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-232	Closed	-$31K	–	450
2022 Q3	$31K	Buy	232 +5	+2%	+$760	﹤0.01%	552
2022 Q2	$35K	Hold	227	–	–	﹤0.01%	541
2022 Q1	$35K	Hold	227	–	–	﹤0.01%	586
2021 Q4	$29K	Sell	227 -39	-15%	-$5.13K	﹤0.01%	629
2021 Q3	$35K	Buy	266 +39	+17%	+$5.89K	﹤0.01%	571
2021 Q2	$40K	Hold	227	–	–	﹤0.01%	513
2021 Q1	$37K	Hold	227	–	–	﹤0.01%	531
2020 Q4	$37K	Hold	227	–	–	﹤0.01%	530
2020 Q3	$32K	Hold	227	–	–	﹤0.01%	519
2020 Q2	$25K	Hold	227	–	–	﹤0.01%	554
2020 Q1	$23K	Hold	227	–	–	﹤0.01%	571
2019 Q4	$34K	Hold	227	–	–	﹤0.01%	584
2019 Q3	$29K	Buy	+227	New	+$30.4K	﹤0.01%	596

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

MUFG Americas's JAZZ Position: Q4 2022 in Review

MUFG Americas sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2022, closing a stake of 232 shares — an estimated $31K sold.

MUFG Americas first reported a position in JAZZ in Q3 2019 and held it in 13 quarters. The position peaked at $40K in Q2 2021. 485 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

MUFG Americas reported no remaining Jazz Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
MUFG Americas sold 232 Jazz Pharmaceuticals shares in Q4 2022, an estimated $31K.
MUFG Americas first reported a position in Jazz Pharmaceuticals in Q3 2019 and held it in 13 quarters.
MUFG Americas's Jazz Pharmaceuticals position peaked at $40K in Q2 2021.
485 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.